The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s CRC screening test, ColoSense.

MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

Edwards Lifesciences has lifted its 2025 profit outlook to between 9%-10%, up from 8%-10%, amid strong Q2 2025 performance in its Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral ...

The UK and India’s new £4.8bn free trade agreement (FTA) is expected to allow new opportunities for Indian medical device and pharmaceutical manufacturers.